Find Gefapixant Citrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1015787-98-0, Af-219, Mk-7264, Gefapixant [usan], Ro4926219, Rg-1646
Molecular Formula
C14H19N5O4S
Molecular Weight
353.40  g/mol
InChI Key
HLWURFKMDLAKOD-UHFFFAOYSA-N
FDA UNII
6K6L7E3F1L

Gefapixant Citrate
Gefapixant is under investigation in clinical trial NCT02397460 (Effect of Gefapixant (AF-219/MK-7264) on Cough Reflex Sensitivity).
1 2D Structure

Gefapixant Citrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide
2.1.2 InChI
InChI=1S/C14H19N5O4S/c1-7(2)8-4-10(22-3)12(24(17,20)21)5-9(8)23-11-6-18-14(16)19-13(11)15/h4-7H,1-3H3,(H2,17,20,21)(H4,15,16,18,19)
2.1.3 InChI Key
HLWURFKMDLAKOD-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)C1=CC(=C(C=C1OC2=CN=C(N=C2N)N)S(=O)(=O)N)OC
2.2 Other Identifiers
2.2.1 UNII
6K6L7E3F1L
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-((2,4-diamino-5-pyrimidinyl)oxy)-4-isopropyl-2-methoxybenzenesulfonamide

2. Af-219

3. Benzenesulfonamide, 5-((2,4-diamino-5-pyrimidinyl)oxy)-2-methoxy-4-(1-methylethyl)-

4. Mk-7264

2.3.2 Depositor-Supplied Synonyms

1. 1015787-98-0

2. Af-219

3. Mk-7264

4. Gefapixant [usan]

5. Ro4926219

6. Rg-1646

7. Ro-4926219

8. Benzenesulfonamide, 5-[(2,4-diamino-5-pyrimidinyl)oxy]-2-methoxy-4-(1-methylethyl)-

9. 6k6l7e3f1l

10. R-1646

11. Af219

12. Rg1646

13. Mk-7264;af-219

14. R1646

15. 5-[(2,4-diaminopyrimidin-5-yl)oxy]-2-methoxy-4-(propan-2-yl)benzene-1-sulfonamide

16. C14h19n5o4s

17. 5-((2,4-diaminopyrimidin-5-yl)oxy)-4-isopropyl-2-methoxybenzenesulfonamide

18. 5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide

19. 5-[(2,4-diamino-5-pyrimidinyl)oxy]-4-isopropyl-2-methoxybenzenesulfonamide

20. 5-((2,4-diaminopyrimidin-5-yl)oxy)-2-methoxy-4-(propan-2-yl)benzenesulfonamide

21. 5-[2,4-bis(azanyl)pyrimidin-5-yl]oxy-2-methoxy-4-propan-2-yl-benzenesulfonamide

22. Benzenesulfonamide, 5-((2,4-diamino-5-pyrimidinyl)oxy)-2-methoxy-4-(1-methylethyl)-

23. 5-((2,4-diamino-5-pyrimidinyl)oxy)-4-isopropyl-2-methoxybenzenesulfonamide

24. Gefapixant [inn]

25. Gefapixant (usan/inn)

26. Gefapixant [who-dd]

27. Unii-6k6l7e3f1l

28. Gtpl9540

29. Schembl1493905

30. Chembl3716057

31. Dtxsid401337212

32. Amy27911

33. Bcp26079

34. Ex-a2788

35. Gefapixant(af-219,mk-7264)

36. Bdbm50533006

37. Mfcd24539325

38. S6664

39. Akos037515637

40. Zinc116342482

41. Db15097

42. Af-219; Mk-7264

43. Ac-35643

44. As-78086

45. Bm170818

46. Sy282739

47. Hy-101588

48. Cs-0021727

49. Ro 4926219

50. J3.556.891c

51. D11349

52. A934898

53. 2-methoxy-4-isopropyl-5-(2,4-diamino-5-pyrimidinyloxy)benzenesulfonamide

54. 5-(2,4-diamino-pyrimidin-5-yloxy)-4-isopropyl-2-methoxy-benzenesulfonamide

55. Af9

2.4 Create Date
2008-04-21
3 Chemical and Physical Properties
Molecular Weight 353.40 g/mol
Molecular Formula C14H19N5O4S
XLogP30.7
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count5
Exact Mass353.11577528 g/mol
Monoisotopic Mass353.11577528 g/mol
Topological Polar Surface Area165 Ų
Heavy Atom Count24
Formal Charge0
Complexity512
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 ATC Code

R - Respiratory system

R05 - Cough and cold preparations

R05D - Cough suppressants, excl. combinations with expectorants

R05DB - Other cough suppressants

R05DB29 - Gefapixant


Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Looking for 1015787-98-0 / Gefapixant Citrate API manufacturers, exporters & distributors?

Gefapixant Citrate manufacturers, exporters & distributors 1

89

PharmaCompass offers a list of Gefapixant Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gefapixant Citrate manufacturer or Gefapixant Citrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gefapixant Citrate manufacturer or Gefapixant Citrate supplier.

PharmaCompass also assists you with knowing the Gefapixant Citrate API Price utilized in the formulation of products. Gefapixant Citrate API Price is not always fixed or binding as the Gefapixant Citrate Price is obtained through a variety of data sources. The Gefapixant Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Gefapixant Citrate

Synonyms

1015787-98-0, Af-219, Mk-7264, Gefapixant [usan], Ro4926219, Rg-1646

Cas Number

1015787-98-0

Unique Ingredient Identifier (UNII)

6K6L7E3F1L

About Gefapixant Citrate

Gefapixant is under investigation in clinical trial NCT02397460 (Effect of Gefapixant (AF-219/MK-7264) on Cough Reflex Sensitivity).

Gefapixant Manufacturers

A Gefapixant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gefapixant, including repackagers and relabelers. The FDA regulates Gefapixant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gefapixant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Gefapixant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Gefapixant Suppliers

A Gefapixant supplier is an individual or a company that provides Gefapixant active pharmaceutical ingredient (API) or Gefapixant finished formulations upon request. The Gefapixant suppliers may include Gefapixant API manufacturers, exporters, distributors and traders.

click here to find a list of Gefapixant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Gefapixant GMP

Gefapixant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Gefapixant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gefapixant GMP manufacturer or Gefapixant GMP API supplier for your needs.

Gefapixant CoA

A Gefapixant CoA (Certificate of Analysis) is a formal document that attests to Gefapixant's compliance with Gefapixant specifications and serves as a tool for batch-level quality control.

Gefapixant CoA mostly includes findings from lab analyses of a specific batch. For each Gefapixant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Gefapixant may be tested according to a variety of international standards, such as European Pharmacopoeia (Gefapixant EP), Gefapixant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gefapixant USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty